Diagnosis, Treatment, and Prognosis of Neuroendocrine Neoplasms
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: 30 July 2025 | Viewed by 39
Special Issue Editors
Interests: diagnosis; medical treatment; radionuclide treatment; prognosis
Interests: targeted immunotherapy; targeted photodynamic therapy; vascular tissue; necrosis; neoplasms; macular degeneration; choroidal neovascularization; lung neoplasms; breast neoplasms; neoplasm metastasis; melanoma; tumor immunology; immunotherapy; particularly antibody and CAR-NK cell immunotherapy; photodynamic therapy; gene therapy; cancer pathology; tumor angiogenesis; tumor microenvironment; immune cells; NK cells; MDSC; cancer stem cells
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The landscape of neuroendocrine neoplasms (NENs) is changing. Previous studies have reported differences in treatment responses, which paved the way for new WHO classifications. The changes in classification have led to an increased demand for access to high pathological expertise. Previously, NENs were solely divided according to Ki-67 proliferation index, but due to new knowledge, NENs are now divided according to Ki-67 proliferation index and differentiation into either highly differentiated neoplasms, neuroendocrine tumors (NETs), and low-differentiated neoplasms, neuroendocrine carcinomas (NECs).
Previously, tumors with KI-67 proliferation index >20% were considered highly malignant and could only be treated with chemotherapy. However, different studies showed that highly differentiated tumors have a better prognosis and similar treatment responses as tumors with Ki-67 proliferation index <20%. Therefore, the treatment of highly differentiated tumors irrespective of KI-67 proliferation index is changing with the additional use of peptide receptor radionuclide therapy, whereas low-differentiated tumors can currently only be treated with chemotherapy.
The scope of this Special Issue is to present new advances within the diagnosis, treatment, and prognosis of NENs. Therefore, we welcome reviews and original articles which focus on both clinical, translational, epidemiological, and basic science in order to highlight the advances.
Dr. Pernille Holmager
Dr. Zhiwei Hu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diagnosis
- medical treatment
- radionuclide treatment
- prognosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
